	Survival after cessation of immunotherapies in melanoma: AÂ systematic review and meta-analysis. J Eur Acad Dermatol Venereol Mayer KE, Warburton L, Zaremba A, Preis S, Foerster Y, Biedermann T, Persa OD. PMID: 40181695 [PubMed - as supplied by publisher]
	A qualitative prognostic biomarker for melanoma based on the relative methylation orderings of CpG loci. Epigenetics Huo Y, Gao Y, Ruan J, Wang L, Li H, Hong G. PMID: 40181653 [PubMed - indexed for MEDLINE]
	Physical activity and mortality in melanoma patients within the Norwegian Women and Cancer study (NOWAC). Int J Cancer Perrier F, Ahimbisibwe A, Ghiasvand R, Rueegg CS, Green AC, Borch KB, Braaten T, Weiderpass E, Valberg M, Robsahm TE, Veierød MB. PMID: 40181554 [PubMed - as supplied by publisher]
	Improving diagnostic accuracy in atypical melanocytic tumors using p16 immunohistochemistry and 9p21 fluorescence in situ hybridization: analysis of 206 second opinion cases. Sci Rep Vergara R, Laharanne E, de la Fouchardière A, Gros A, Merlio JP, Guyon M, Dutriaux C, Beylot-Barry M, Vergier B, Beltzung F. PMID: 40181071 [PubMed - indexed for MEDLINE]
	Cutaneous melanoma. Nat Rev Dis Primers Tasdogan A, Sullivan RJ, Katalinic A, Lebbe C, Whitaker D, Puig S, van de Poll-Franse LV, Massi D, Schadendorf D. PMID: 40180935 [PubMed - indexed for MEDLINE]
	BAX as a Biomarker for Predicting Immunotherapeutic Efficacy in Uveal Melanoma Patients: A Comprehensive Analysis. Mol Biotechnol Shi Y, Lei C, Jiang H, Hong Y, Su W, Wu S, Yang X. PMID: 40180694 [PubMed - as supplied by publisher]
	Wise or wide (WoW) study protocol: a national, multicentre, prospective, randomised and controlled, parallel group, non-inferiority study to compare single-staged versus two-staged excisions of thin invasive (â‰¤1.0 mm) melanoma. BMJ Open Wennberg E, Claeson M, Olofsson Bagge R, Polesie S, Paoli J. PMID: 40180392 [PubMed - indexed for MEDLINE]
	Recurrent vismodegib drug-induced liver injury with corticosteroid response. BMJ Case Rep Bienz M, Fife K, Paterson A, Webb G. PMID: 40180349 [PubMed - indexed for MEDLINE]
	Exosomes in melanoma: Future potential for clinical theranostics. Pathol Res Pract Das A, Sonar S, Dhar R, Subramaniyan V. PMID: 40179441 [PubMed - as supplied by publisher]
	Topical imiquimod and inÂ situ vulvar melanoma: A promising therapy? Int J Gynaecol Obstet Pepe F, Silvestri F, Preti EP, Iacobone AD, Radici G, Vaccari S, Queirolo P, Tosti G. PMID: 40178409 [PubMed - as supplied by publisher]
	Exploring recent advances in signaling pathways and hallmarks of uveal melanoma: a comprehensive review. Explor Target Antitumor Ther Banimohammad M, Khalafi P, Gholamin D, Bangaleh Z, Akhtar N, Solomon AD, Prabhakar PK, Sanami S, Prakash A, Pazoki-Toroudi H. PMID: 40177537 [PubMed]
	Dermoscopic Aspects of Cutaneous Melanoma and Non-Melanoma Skin Cancer. Curr Pharm Des Escobar GF, Pauvels LSP, Bakos RM. PMID: 40176692 [PubMed - as supplied by publisher]
	Absolute Risk of Developing a Second Primary Cancer After a First Primary Melanoma: An Australian Population-Based Cohort Study. Am J Epidemiol Ni Y, Watts CG, Varey AHR, Cust AE, Lo SN. PMID: 40176284 [PubMed - as supplied by publisher]
	Consolidation Chemotherapy Provided Survival Benefit for Esophageal Squamous Cell Carcinoma Patients Who Underwent Concurrent Chemoradiotherapy Lower Than 60â€‰Gy. Thorac Cancer Zhang H, Wang Q, Wang P, Tang B. PMID: 40176263 [PubMed - indexed for MEDLINE]
	Microsecretory adenocarcinoma: simplifying the diagnosis of a recently recognized salivary gland and cutaneous adnexal neoplasm. Diagn Pathol Abdelmoneim NA, Elfouly AM, Abou Madawi NA. PMID: 40176070 [PubMed - indexed for MEDLINE]
	Multi-modal radiomics features to predict overall survival of locally advanced esophageal cancer after definitive chemoradiotherapy. BMC Cancer Yu N, Wan Y, Zuo L, Cao Y, Qu D, Liu W, Deng L, Zhang T, Wang W, Wang J, Lv J, Xiao Z, Feng Q, Zhou Z, Bi N, Niu T, Wang X. PMID: 40175977 [PubMed - indexed for MEDLINE]
	Reconsidering the surgical approach in cutaneous melanoma: does wide local excision after a complete diagnostic excision reduce the risk of recurrence? Eur J Cancer Stekelenburg I, Laeijendecker AE, van Doorn RC, Doeksen A, Blokx WAM, Schrage YM, van Akkooi ACJ, Scolyer RA, Postma EL, Sharouni MAE. PMID: 40175258 [PubMed - as supplied by publisher]
	Evaluation of residual tumour in wide local excision for melanoma: A nationwide population-based study. Eur J Cancer Schurink AW, Verhoef C, Waalboer-Spuij R, Mooyaart A, Grünhagen DJ. PMID: 40175257 [PubMed - as supplied by publisher]
	Critical evaluation of sentinel lymph node biopsy in pT1b and pT2a melanoma patients: A nationwide population-based study. Eur J Cancer Stassen RC, Schurink AW, van der Veldt AAM, Hollestein LM, Verhoef PC, Grünhagen DJ. PMID: 40175255 [PubMed - as supplied by publisher]
	Patterns of Failure in Cutaneous Head and Neck Melanoma Following Negative Sentinel Lymph Node Biopsy: A Retrospective Cohort Study. Am Surg Staibano P, Xie M, Abdallah Z, Nguyen S, Au M, Zhou K, Bensky H, Gupta MK, Choi DL, Lewis TA, Young JEMT, Zhang H. PMID: 40173081 [PubMed - as supplied by publisher]

Articles 1 - 20 / 133008

Page 1 of 6651



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy